October 21, 2023

Immunocore presents three-year overall survival data from the KIMMTRAK Phase 3 trial

Data published in New England Journal of Medicine and presented as a late breaking abstract in mini oral session at ESMO Congress 2023 KIMMTRAK demonstrated long-term survival benefit in HLA-A*02:01 positive patients with previously untreated metastatic uveal melanoma (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md, 21 October 2023) Immunocore

>

Indonesia’s campaign at the UN Human Rights Council

Indonesia will begin its term of office as the United Nations Human Rights Council member on January 1, 2024, with several agendas to advance and protect human rights at the national, regional, and international levels.Indonesia was elected to regain …

>